ReP USP - Resultado da busca

Artigo de periodico
Pep19 has a positive effect on insulin sensitivity and ameliorates both hepatic and adipose tissue phenotype of diet-induced obese mice (2022)
Silvério, Renata ; Barth, Robson; Heimann, Andrea S. ; Reckziegel, Patrícia ; Santos, Gustavo J. dos ; Zerbo, Silvana Y. Romero ; Silva, Francisco Javier Bermúdez ; Rafacho, Alex ; Ferro, Emer Suavinho
Source: International Journal of Molecular Sciences. Unidade: ICB
Subjects: FARMACOLOGIA, DIETA ANIMAL, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, TECIDO ADIPOSO, RESISTÊNCIA À INSULINA, OBESIDADE, PEPTÍDEOS, MICRORNAS, FÍGADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVÉRIO, Renata et al. Pep19 has a positive effect on insulin sensitivity and ameliorates both hepatic and adipose tissue phenotype of diet-induced obese mice. International Journal of Molecular Sciences, v. 23, n. 8, p. 1-19, 2022Tradução . . Disponível em: https://doi.org/10.3390/ijms23084082. Acesso em: 16 nov. 2024.
APA
Silvério, R., Barth, R., Heimann, A. S., Reckziegel, P., Santos, G. J. dos, Zerbo, S. Y. R., et al. (2022). Pep19 has a positive effect on insulin sensitivity and ameliorates both hepatic and adipose tissue phenotype of diet-induced obese mice. International Journal of Molecular Sciences, 23( 8), 1-19. doi:10.3390/ijms23084082
NLM
Silvério R, Barth R, Heimann AS, Reckziegel P, Santos GJ dos, Zerbo SYR, Silva FJB, Rafacho A, Ferro ES. Pep19 has a positive effect on insulin sensitivity and ameliorates both hepatic and adipose tissue phenotype of diet-induced obese mice [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 8): 1-19.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ijms23084082
Vancouver
Silvério R, Barth R, Heimann AS, Reckziegel P, Santos GJ dos, Zerbo SYR, Silva FJB, Rafacho A, Ferro ES. Pep19 has a positive effect on insulin sensitivity and ameliorates both hepatic and adipose tissue phenotype of diet-induced obese mice [Internet]. International Journal of Molecular Sciences. 2022 ; 23( 8): 1-19.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ijms23084082
Artigo de periodico
A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury (2022)
Qvit, Nir ; Lin, Amanda J. ; Elezaby, Aly ; Ostberg, Nicolai P. ; Campos, Juliane Cruz ; Ferreira, Julio Cesar Batista ; Rosen, Daria Mochly
Source: Pharmaceuticals. Unidade: ICB
Subjects: ANATOMIA, ISQUEMIA MIOCÁRDICA, TROPONINA I, PROTEÍNAS MUSCULARES, PEPTÍDEOS, INFARTO DO MIOCÁRDIO, CARDIOPATIAS, AMINOÁCIDOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QVIT, Nir et al. A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury. Pharmaceuticals, v. 15, n. 3, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.3390/ph15030271. Acesso em: 16 nov. 2024.
APA
Qvit, N., Lin, A. J., Elezaby, A., Ostberg, N. P., Campos, J. C., Ferreira, J. C. B., & Rosen, D. M. (2022). A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury. Pharmaceuticals, 15( 3), 1-11. doi:10.3390/ph15030271
NLM
Qvit N, Lin AJ, Elezaby A, Ostberg NP, Campos JC, Ferreira JCB, Rosen DM. A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury [Internet]. Pharmaceuticals. 2022 ; 15( 3): 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ph15030271
Vancouver
Qvit N, Lin AJ, Elezaby A, Ostberg NP, Campos JC, Ferreira JCB, Rosen DM. A selective inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a treatment for Ischemia-reperfusion injury [Internet]. Pharmaceuticals. 2022 ; 15( 3): 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ph15030271
Parte de monografia/livro
Intracellular peptides as drug prototypes (2022)
Gewehr, Mayara Calegaro Ferrari ; Navon, Ami ; Ferro, Emer Suavinho
Source: Peptide and Peptidomimetic Therapeutics. Unidade: ICB
Subjects: PEPTÍDEOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GEWEHR, Mayara Calegaro Ferrari e NAVON, Ami e FERRO, Emer Suavinho. Intracellular peptides as drug prototypes. Peptide and Peptidomimetic Therapeutics. Tradução . Amsterdam: Elsevier B. V., 2022. . Disponível em: https://doi.org/10.1016/B978-0-12-820141-1.00002-9. Acesso em: 16 nov. 2024.
APA
Gewehr, M. C. F., Navon, A., & Ferro, E. S. (2022). Intracellular peptides as drug prototypes. In Peptide and Peptidomimetic Therapeutics. Amsterdam: Elsevier B. V. doi:10.1016/B978-0-12-820141-1.00002-9
NLM
Gewehr MCF, Navon A, Ferro ES. Intracellular peptides as drug prototypes [Internet]. In: Peptide and Peptidomimetic Therapeutics. Amsterdam: Elsevier B. V.; 2022. [citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/B978-0-12-820141-1.00002-9
Vancouver
Gewehr MCF, Navon A, Ferro ES. Intracellular peptides as drug prototypes [Internet]. In: Peptide and Peptidomimetic Therapeutics. Amsterdam: Elsevier B. V.; 2022. [citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/B978-0-12-820141-1.00002-9
Artigo de periodico
Why do mice squeak? Toward a better understanding of defensive vocalization (2022)
Ruat, Julia ; Genewsky, Andreas J. ; Heinz, Daniel E. ; Kaltwasser, Sebastian F.; Canteras, Newton Sabino ; Czisch, Michael ; Chen, Alon ; Wotjak, Carsten T.
Source: iScience. Unidade: ICB
Subjects: ANATOMIA, RATOS, CAMUNDONGOS, COMPORTAMENTO ANIMAL, ANSIEDADE, SUBSTÂNCIA CINZENTA PERIAQUEDUTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUAT, Julia et al. Why do mice squeak? Toward a better understanding of defensive vocalization. iScience, v. 25, n. 7, p. 1-21, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.isci.2022.104657. Acesso em: 16 nov. 2024.
APA
Ruat, J., Genewsky, A. J., Heinz, D. E., Kaltwasser, S. F., Canteras, N. S., Czisch, M., et al. (2022). Why do mice squeak? Toward a better understanding of defensive vocalization. iScience, 25( 7), 1-21. doi:10.1016/j.isci.2022.104657
NLM
Ruat J, Genewsky AJ, Heinz DE, Kaltwasser SF, Canteras NS, Czisch M, Chen A, Wotjak CT. Why do mice squeak? Toward a better understanding of defensive vocalization [Internet]. iScience. 2022 ; 25( 7): 1-21.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.isci.2022.104657
Vancouver
Ruat J, Genewsky AJ, Heinz DE, Kaltwasser SF, Canteras NS, Czisch M, Chen A, Wotjak CT. Why do mice squeak? Toward a better understanding of defensive vocalization [Internet]. iScience. 2022 ; 25( 7): 1-21.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.isci.2022.104657
Artigo de periodico-carta/editorial
Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β (2021)
Vinh, Donald C. ; Abel, Laurent ; Bastard, Paul ; Cheng, Matthew P. ; Condino Neto, Antonio ; Gregersen, Peter K. ; Haerynck, Filomeen ; Cicalese, Maria-Pia ; Hagin, David; Palacín, Pere Soler ; Planas, Anna M. ; Pujol, Aurora ; Notarangelo, Luigi D. ; Zhang, Qian ; Su, Helen C. ; Casanova, Jean-Laurent ; Meyts, Isabelle
Source: Journal of Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNIDADE, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, IMUNOGENÉTICA, COVID-19, INTERFERON TIPO I, INFECÇÕES POR CORONAVIRUS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VINH, Donald C. et al. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s10875-021-01068-6. Acesso em: 16 nov. 2024. , 2021
APA
Vinh, D. C., Abel, L., Bastard, P., Cheng, M. P., Condino Neto, A., Gregersen, P. K., et al. (2021). Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β. Journal of Clinical Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1007/s10875-021-01068-6
NLM
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Vancouver
Vinh DC, Abel L, Bastard P, Cheng MP, Condino Neto A, Gregersen PK, Haerynck F, Cicalese M-P, Hagin D, Palacín PS, Planas AM, Pujol A, Notarangelo LD, Zhang Q, Su HC, Casanova J-L, Meyts I. Harnessing Type I IFN immunity against SARS-CoV-2 with early administration of IFN-β [Internet]. Journal of Clinical Immunology. 2021 ; 1-18.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10875-021-01068-6
Artigo de periodico
Hemopressin as a breakthrough for the cannabinoid field (2021)
Heimann, Andrea S. ; Dale, Camila Squarzoni ; Guimarães, Francisco Silveira ; Reis, Ricardo A. M. ; Navon, Ami ; Shmuelov, Michal A.; Rioli, Vanessa; Gomes, Ivone; Devi, Lakshmi L.; Ferro, Emer Suavinho
Source: Neuropharmacology. Unidades: ICB, FMRP
Subjects: ANATOMIA, FARMACOLOGIA, CANABINOIDES, RECEPTORES, PEPTÍDEOS, HEMOGLOBINAS, CAMUNDONGOS, MITOCÔNDRIAS, ANTI-INFLAMATÓRIOS, MATERIAIS NANOESTRUTURADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HEIMANN, Andrea S. et al. Hemopressin as a breakthrough for the cannabinoid field. Neuropharmacology, v. 183, p. 12 , 2021Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2020.108406. Acesso em: 16 nov. 2024.
APA
Heimann, A. S., Dale, C. S., Guimarães, F. S., Reis, R. A. M., Navon, A., Shmuelov, M. A., et al. (2021). Hemopressin as a breakthrough for the cannabinoid field. Neuropharmacology, 183, 12 . doi:10.1016/j.neuropharm.2020.108406
NLM
Heimann AS, Dale CS, Guimarães FS, Reis RAM, Navon A, Shmuelov MA, Rioli V, Gomes I, Devi LL, Ferro ES. Hemopressin as a breakthrough for the cannabinoid field [Internet]. Neuropharmacology. 2021 ; 183 12 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.neuropharm.2020.108406
Vancouver
Heimann AS, Dale CS, Guimarães FS, Reis RAM, Navon A, Shmuelov MA, Rioli V, Gomes I, Devi LL, Ferro ES. Hemopressin as a breakthrough for the cannabinoid field [Internet]. Neuropharmacology. 2021 ; 183 12 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.neuropharm.2020.108406
Artigo de periodico
Peptidomic profiling of cerebrospinal fluid from patients with intracranial saccular aneurysms (2021)
Sakaya, Gabriel R. ; Parada, Carolina Angélica da Silva ; Eichler, Rosangela Aparecida dos Santos ; Yamaki, Vitor N. ; Navon, Ami ; Heimann, Andrea S.; Figueiredo, Eberval Gadelha ; Ferro, Emer Suavinho
Source: Journal of Proteomics. Unidades: ICB, FM
Subjects: FARMACOLOGIA, BIOMARCADORES, PEPTÍDEOS, LÍQUIDO CEFALORRAQUIDIANO, ANEURISMA INTRACRANIANO, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAKAYA, Gabriel R. et al. Peptidomic profiling of cerebrospinal fluid from patients with intracranial saccular aneurysms. Journal of Proteomics, v. 240, p. 1-13, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jprot.2021.104188. Acesso em: 16 nov. 2024.
APA
Sakaya, G. R., Parada, C. A. da S., Eichler, R. A. dos S., Yamaki, V. N., Navon, A., Heimann, A. S., et al. (2021). Peptidomic profiling of cerebrospinal fluid from patients with intracranial saccular aneurysms. Journal of Proteomics, 240, 1-13. doi:10.1016/j.jprot.2021.104188
NLM
Sakaya GR, Parada CA da S, Eichler RA dos S, Yamaki VN, Navon A, Heimann AS, Figueiredo EG, Ferro ES. Peptidomic profiling of cerebrospinal fluid from patients with intracranial saccular aneurysms [Internet]. Journal of Proteomics. 2021 ; 240 1-13.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jprot.2021.104188
Vancouver
Sakaya GR, Parada CA da S, Eichler RA dos S, Yamaki VN, Navon A, Heimann AS, Figueiredo EG, Ferro ES. Peptidomic profiling of cerebrospinal fluid from patients with intracranial saccular aneurysms [Internet]. Journal of Proteomics. 2021 ; 240 1-13.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jprot.2021.104188
Artigo de periodico
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)
Bastard, Paul ; Gervais, Adrian ; Voyer, Tom Le ; Rosain, Jérémie ; Philippot, Quentin; Manry, Jérémy ; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich ; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Liis, Haljasmägi; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; Prost, Nicolas de; Tandjaoui-Lambiotte, Yacine; Luyt , Charles-Edouard; Amador-Borrero, Blanca; Alexandre, Gaudet; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey B; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Megarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James R; Franco, José Luis; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa; Biondi, Andrea; Bonfanti, Paolo; Castagnoli, Riccardo; Delmonte, Ottavia M; Zhang, Yu; Snow, Andrew L; Holland, Steven M; Biggs, Catherine M; Moncada-Vélez, Marcela; Arias, Andrés Augusto; Lorenzo, Lazaro; Boucherit, Soraya; Coulibaly, Boubacar; Anglicheau, Dany; Planas, Anna M; Haerynck, Filomeen; Duvlis, Sotirija; Nussbaum, Robert L; Ozcelik, Tayfun; Keles, Sevgi; Bousfiha, Ahmed A; ElBakkouri, Jalila; Ramirez-Santana, Carolina; Paul, Stéphane; Pan-Hammarström, Qiang; Hammarström, Lennart; Dupont, Annabelle; Kurolap, Alina; Metz, Christine N; Aiuti, Alessandro; Casari, Giorgio; Lampasona, Vito; Ciceri, Fabio; Barreiros, Lucila A; Dominguez-Garrido, Elena; Vidigal, Mateus; Zatz, Mayana ; Beek, Diederik van de; Sahanic, Sabina; Tancevski, Ivan; Stepanovskyy, Yurii; Boyarchuk, Oksana; Nukui, Yoko; Tsumura, Miyuki; Vidaur, Loreto; Tangye, Stuart G; Burrel, Sonia; Duffy, Darragh; Quintana-Murci, Lluis; Klocperk, Adam; Kann, Nelli Y; Shcherbina, Anna; Lau, Yu-Lung; Leung, Daniel; Coulongeat, Matthieu; Marlet, Julien; Koning, Rutger; Reyes, Luis Felipe; Chauvineau-Grenier, Angélique; Vene, Fabienne; Monneret, Guillaume; Nussenzweig, Michel C; Arrestier, Romain; Boudhabhay, Idris; Baris-Feldman, Hagit; Hagin, David; Wauters, Joost; Meyts, Isabelle; Dyer, Adam H; Kennelly, Sean P; Bourke, Nollaig M; Halwani, Rabih; Sharif-Askari, Narjes Saheb; Dorgham, Karim; Sallette, Jérome; Sedkaoui, Souad Mehlal; AlKhater, Suzan; Rigo-Bonnin, Raúl; Morandeira, Francisco; Roussel, Lucie; Vinh, Donald C; Ostrowski, Sisse Rye; Condino Neto, Antonio ; Prando, Carolina ; Bondarenko, Anastasiia; Spaan, András N; Gilardin, Laurent; Fellay, Jacques; Lyonnet, Stanislas; Bilguvar, Kaya; Lifton, Richard P; Mane, Shrikant; Anderson, Mark S; Boisson, Bertrand; Béziat, Vivien; Zhang, Shen-Ying; Andreakos, Evangelos; Hermine, Olivier; Pujol, Aurora; Peterson, Pärt; Mogensen, Trine; H Rowen, Lee; Mond, James; Debette, Stéphanie; Lamballerie, Xavier de; Duval, Xavier; Mentré, France; Zins, Marie; Soler-Palacin, Pere; Colobran, Roger; Gorochov, Guy; Solanich, Xavier; Susen, Sophie; Martinez-Picado, Javier; Raoult, Didier; Vasse, Marc; Gregersen, Peter K; Piemonti, Lorenzo; Rodríguez-Gallego, Carlos; Notarangelo, Luigi D; Su, Helen C; Kisand, Kai; Okada, Satoshi; Puel, Anne; Jouanguy, Emmanuelle; Rice, Charles M; Tiberghien, Pierre; Zhang, Qian; Cobat, Aurélie; Abel, Laurent; Casanova, Jean-Laurent
Source: Science Immunology. Unidades: IB, ICB
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, ANTICORPOS, IMUNOLOGIA, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 16 nov. 2024.
APA
Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340
NLM
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Vancouver
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Artigo de periodico
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update) (2021)
Roos, Dirk; Leeuwen, Karin van; Hsu, Amy P.; Priel, Debra Long ; Begtrup, Amber ; Brandon, Rhonda; Stasia, Marie José ; Bakri, Faris Ghalib ; Köker, Nezihe ; Köker, Mustafa Yavuz ; Madkaika, Manisha; Boer, Martin de ; Morato, Maria Bravo Garcia ; Shephard, Juan Luis Valdivieso; Roesler, Joachim ; Kanegane, Hirokazu ; Kawai, Toshinao ; Matteo, Gigliola Di ; Shahrooei, Mohammad ; Bustamante, Jacinta ; Rawat, Amit ; Vignesh, Pandiarajan ; Mortaz, Esmaeil ; Fayezi, Abbas; Cagdas, Deniz ; Tezcan, Ilhan ; Kitcharoensakkul, Maleewan ; Dinauer, Mary C. ; Meyts, Isabelle; Wolach, Baruch; Condino Neto, Antonio ; Zerbe, Christa S. ; Holland, Steven M.; Malech, Harry L. ; Gallin, John I.; Kuhns, Douglas B.
Source: Blood Cells, Molecules and Diseases. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, MUTAÇÃO GENÉTICA, DOENÇAS SANGUÍNEAS E LINFÁTICAS, SUPERÓXIDO DISMUTASE, ATIVAÇÃO ENZIMÁTICA, IMUNOGENÉTICA, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROOS, Dirk et al. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells, Molecules and Diseases, v. 90, p. 1-36, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2021.102587. Acesso em: 16 nov. 2024.
APA
Roos, D., Leeuwen, K. van, Hsu, A. P., Priel, D. L., Begtrup, A., Brandon, R., et al. (2021). Hematologically important mutations: X-linked chronic granulomatous disease (fourth update). Blood Cells, Molecules and Diseases, 90, 1-36. doi:10.1016/j.bcmd.2021.102587
NLM
Roos D, Leeuwen K van, Hsu AP, Priel DL, Begtrup A, Brandon R, Stasia MJ, Bakri FG, Köker N, Köker MY, Madkaika M, Boer M de, Morato MBG, Shephard JLV, Roesler J, Kanegane H, Kawai T, Matteo GD, Shahrooei M, Bustamante J, Rawat A, Vignesh P, Mortaz E, Fayezi A, Cagdas D, Tezcan I, Kitcharoensakkul M, Dinauer MC, Meyts I, Wolach B, Condino Neto A, Zerbe CS, Holland SM, Malech HL, Gallin JI, Kuhns DB. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update) [Internet]. Blood Cells, Molecules and Diseases. 2021 ; 90 1-36.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.bcmd.2021.102587
Vancouver
Roos D, Leeuwen K van, Hsu AP, Priel DL, Begtrup A, Brandon R, Stasia MJ, Bakri FG, Köker N, Köker MY, Madkaika M, Boer M de, Morato MBG, Shephard JLV, Roesler J, Kanegane H, Kawai T, Matteo GD, Shahrooei M, Bustamante J, Rawat A, Vignesh P, Mortaz E, Fayezi A, Cagdas D, Tezcan I, Kitcharoensakkul M, Dinauer MC, Meyts I, Wolach B, Condino Neto A, Zerbe CS, Holland SM, Malech HL, Gallin JI, Kuhns DB. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update) [Internet]. Blood Cells, Molecules and Diseases. 2021 ; 90 1-36.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.bcmd.2021.102587
Artigo de periodico
The potential anti-inflammatory and anti-nociceptive effects of rat hemopressin (PVNFKFLSH) in experimental arthritis (2020)
Camargo, Livia de Lucca ; Souza, Alexandre Denadai; Yshii, Lidia M. ; Lima, Carla; Cerqueira, Anderson, R. A.; Gewehr, Mayara Calegaro Ferrari ; Fernandes, Elizabeth Soares ; Schenka, André A. ; Muscará, Marcelo Nicolás ; Ferro, Emer Suavinho ; Costa, Soraia Katia Pereira ; Teixeira, Simone Aparecida
Source: European Journal of Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, CITOCINAS, ARTRITE ANIMAL, RATOS, NEUROPEPTÍDEOS, ANTI-INFLAMATÓRIOS, ARTRITE REUMATOIDE, ARTICULAÇÃO DO JOELHO, ALBUMINAS, LEUCÓCITOS, INTERLEUCINA 6
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMARGO, Livia de Lucca et al. The potential anti-inflammatory and anti-nociceptive effects of rat hemopressin (PVNFKFLSH) in experimental arthritis. European Journal of Pharmacology, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2020.173636. Acesso em: 16 nov. 2024.
APA
Camargo, L. de L., Souza, A. D., Yshii, L. M., Lima, C., Cerqueira, A., Gewehr, M. C. F., et al. (2020). The potential anti-inflammatory and anti-nociceptive effects of rat hemopressin (PVNFKFLSH) in experimental arthritis. European Journal of Pharmacology. doi:10.1016/j.ejphar.2020.173636
NLM
Camargo L de L, Souza AD, Yshii LM, Lima C, Cerqueira A, Gewehr MCF, Fernandes ES, Schenka AA, Muscará MN, Ferro ES, Costa SKP, Teixeira SA. The potential anti-inflammatory and anti-nociceptive effects of rat hemopressin (PVNFKFLSH) in experimental arthritis [Internet]. European Journal of Pharmacology. 2020 ;[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173636
Vancouver
Camargo L de L, Souza AD, Yshii LM, Lima C, Cerqueira A, Gewehr MCF, Fernandes ES, Schenka AA, Muscará MN, Ferro ES, Costa SKP, Teixeira SA. The potential anti-inflammatory and anti-nociceptive effects of rat hemopressin (PVNFKFLSH) in experimental arthritis [Internet]. European Journal of Pharmacology. 2020 ;[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ejphar.2020.173636
Artigo de periodico
Thimet oligopeptidase biochemical and biological significances: past, present, and future directions (2020)
Ferro, Emer Suavinho ; Gewehr, Mayara Calegaro Ferrari ; Navon, Ami
Source: Biomolecules. Unidade: ICB
Subjects: FARMACOLOGIA, OLIGOPEPTÍDEOS, PEPTÍDEOS, TECIDO ANIMAL, ANTÍGENOS DE HISTOCOMPATIBILIDADE, CAMUNDONGOS, RESISTÊNCIA À INSULINA, DIETA ANIMAL, FENÓTIPOS, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRO, Emer Suavinho e GEWEHR, Mayara Calegaro Ferrari e NAVON, Ami. Thimet oligopeptidase biochemical and biological significances: past, present, and future directions. Biomolecules, v. 10, n. 9, p. 28 , 2020Tradução . . Disponível em: https://doi.org/10.3390/biom10091229. Acesso em: 16 nov. 2024.
APA
Ferro, E. S., Gewehr, M. C. F., & Navon, A. (2020). Thimet oligopeptidase biochemical and biological significances: past, present, and future directions. Biomolecules, 10( 9), 28 . doi:10.3390/biom10091229
NLM
Ferro ES, Gewehr MCF, Navon A. Thimet oligopeptidase biochemical and biological significances: past, present, and future directions [Internet]. Biomolecules. 2020 ; 10( 9): 28 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/biom10091229
Vancouver
Ferro ES, Gewehr MCF, Navon A. Thimet oligopeptidase biochemical and biological significances: past, present, and future directions [Internet]. Biomolecules. 2020 ; 10( 9): 28 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/biom10091229
Artigo de periodico
Competition for nutritional resources masks the true frequency of bacterial mutants (2020)
Neves, Henrique Iglesias ; Machado, Gabriella Trombini ; Ramos, Taíssa Cristina dos Santos; Yang, Hyun Mo ; Yagil, Ezra ; Spira, Beny
Source: BMC Biology. Unidades: ICB, IQ, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, MUTAGÊNESE, MUTAÇÃO, COMPOSTOS ORGÂNICOS, CÉLULAS, GENÉTICA BACTERIANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEVES, Henrique Iglesias et al. Competition for nutritional resources masks the true frequency of bacterial mutants. BMC Biology, v. 18, p. 15 , 2020Tradução . . Disponível em: https://doi.org/10.1186/s12915-020-00913-1. Acesso em: 16 nov. 2024.
APA
Neves, H. I., Machado, G. T., Ramos, T. C. dos S., Yang, H. M., Yagil, E., & Spira, B. (2020). Competition for nutritional resources masks the true frequency of bacterial mutants. BMC Biology, 18, 15 . doi:10.1186/s12915-020-00913-1
NLM
Neves HI, Machado GT, Ramos TC dos S, Yang HM, Yagil E, Spira B. Competition for nutritional resources masks the true frequency of bacterial mutants [Internet]. BMC Biology. 2020 ; 18 15 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1186/s12915-020-00913-1
Vancouver
Neves HI, Machado GT, Ramos TC dos S, Yang HM, Yagil E, Spira B. Competition for nutritional resources masks the true frequency of bacterial mutants [Internet]. BMC Biology. 2020 ; 18 15 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1186/s12915-020-00913-1
Artigo de periodico
Modulation of hippocampal neuronal resilience during aging by the Hsp70/Hsp90 co‐chaperone STI1 (2020)
Lackie, Rachel Elizabeth ; Razzaq, Abdul R.; Farhan, Sali M. K.; Qiu, Lily R.; Moshitzky, Gilli; Beraldo, Flavio H.; Lopes, Marilene Hohmuth ; Maciejewski, Andrzej; Gros, Robert ; Fan, Jue ; Choy, Wing-Yiu ; Greenberg, David S. ; Martins, Vilma R. ; Duennwald, Martin L. ; Lerch, Jason P.; Soreq, Hermona ; Prado, Vania F. ; Prado, Marco A. M.
Source: Journal of Neurochemistry. Unidade: ICB
Subjects: BIOLOGIA CELULAR, HIPOCAMPU DE ANIMAL, CAMUNDONGOS, ENVELHECIMENTO CELULAR, MAMÍFEROS, FOSFOPROTEÍNAS, HIPOCAMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LACKIE, Rachel Elizabeth et al. Modulation of hippocampal neuronal resilience during aging by the Hsp70/Hsp90 co‐chaperone STI1. Journal of Neurochemistry, v. 153, n. 6, p. 727-758, 2020Tradução . . Disponível em: https://doi.org/10.1111/jnc.14882. Acesso em: 16 nov. 2024.
APA
Lackie, R. E., Razzaq, A. R., Farhan, S. M. K., Qiu, L. R., Moshitzky, G., Beraldo, F. H., et al. (2020). Modulation of hippocampal neuronal resilience during aging by the Hsp70/Hsp90 co‐chaperone STI1. Journal of Neurochemistry, 153( 6), 727-758. doi:10.1111/jnc.14882
NLM
Lackie RE, Razzaq AR, Farhan SMK, Qiu LR, Moshitzky G, Beraldo FH, Lopes MH, Maciejewski A, Gros R, Fan J, Choy W-Y, Greenberg DS, Martins VR, Duennwald ML, Lerch JP, Soreq H, Prado VF, Prado MAM. Modulation of hippocampal neuronal resilience during aging by the Hsp70/Hsp90 co‐chaperone STI1 [Internet]. Journal of Neurochemistry. 2020 ; 153( 6): 727-758.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/jnc.14882
Vancouver
Lackie RE, Razzaq AR, Farhan SMK, Qiu LR, Moshitzky G, Beraldo FH, Lopes MH, Maciejewski A, Gros R, Fan J, Choy W-Y, Greenberg DS, Martins VR, Duennwald ML, Lerch JP, Soreq H, Prado VF, Prado MAM. Modulation of hippocampal neuronal resilience during aging by the Hsp70/Hsp90 co‐chaperone STI1 [Internet]. Journal of Neurochemistry. 2020 ; 153( 6): 727-758.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/jnc.14882
Artigo de periodico
A perspective on the need and current status of efficient sex separation methods for mosquito genetic control (2018)
Papathanos, Philippos Aris; Kostas, Bourtzis ; Tripet, Frederic ; Bossin, Hervé ; Virginio, Jair Fernandes ; Pedrosa, Michelle Cristine ; Guindo, Amadou ; Sylla, Lakamy; Coulibaly, Mamadou B.; Yao, Franck Adama ; Epopa, Patric stephane ; Diabate, Abdoulaye ; Capurro, Margareth de Lara
Source: Parasites & Vectors. Unidades: ICB, BIOTECNOLOGIA, CENA
Subjects: MOSQUITOS, GENÉTICA ANIMAL, SEXO, ANIMAIS PARASITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAPATHANOS, Philippos Aris et al. A perspective on the need and current status of efficient sex separation methods for mosquito genetic control. Parasites & Vectors, v. 11 Supl. 2, n. 654, p. 165-171, 2018Tradução . . Disponível em: https://doi.org/10.1186/s13071-018-3222-9. Acesso em: 16 nov. 2024.
APA
Papathanos, P. A., Kostas, B., Tripet, F., Bossin, H., Virginio, J. F., Pedrosa, M. C., et al. (2018). A perspective on the need and current status of efficient sex separation methods for mosquito genetic control. Parasites & Vectors, 11 Supl. 2( 654), 165-171. doi:10.1186/s13071-018-3222-9
NLM
Papathanos PA, Kostas B, Tripet F, Bossin H, Virginio JF, Pedrosa MC, Guindo A, Sylla L, Coulibaly MB, Yao FA, Epopa P stephane, Diabate A, Capurro M de L. A perspective on the need and current status of efficient sex separation methods for mosquito genetic control [Internet]. Parasites & Vectors. 2018 ; 11 Supl. 2( 654): 165-171.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1186/s13071-018-3222-9
Vancouver
Papathanos PA, Kostas B, Tripet F, Bossin H, Virginio JF, Pedrosa MC, Guindo A, Sylla L, Coulibaly MB, Yao FA, Epopa P stephane, Diabate A, Capurro M de L. A perspective on the need and current status of efficient sex separation methods for mosquito genetic control [Internet]. Parasites & Vectors. 2018 ; 11 Supl. 2( 654): 165-171.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1186/s13071-018-3222-9
Artigo de periodico
Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery (2016)
Scott, Eric M.; Halees, A.; Itan, Y.; Spencer, E. G.; He,Y.; Azab, M. A.; Gabriel, S. B.; Belkadi, A.; Boisson, B.; Abel, L.; Clark, A. G.; Consortium, Greater Middle East Variome; Alkuraya, F. S.; Casanova, J. L.; Gleeson, J. G.; Rahim, S. A.; Abdel-Hadi, S.; Abdel-Salam, G.; Abdel-Salam, E.; Abdou, M.; Abhytankar, A.; Adimi, P.; Ahmad, J.; Akcakus, M.; Aksu, G.; Hajjar, S. A.; Juamaah, S. A.; Muhsen, S. A.; Sannaa, N. A.; Tameni, S. A.; Al-Aama, J.; Al-Allawi, N.; Al-Baradie, R.; Al-Gazali, L.; Al-Hashem, A.; Al-Herz, W.; Al-Jeaid, D.; Al-Tawari, A.; Alangari, A.; Alcais, A.; AlFawaz, T.; Alsum, Z.; Ammar-Khodja, A.; Amouian, S.; Ammar-Khodja, A.; Arikan, C.; Aryani, O.; Aslanger, A.; Aydogmus, C.; Aytekin, C.; Azam, M.; Bansagi, B.; Barbouche, M. R.; Bastaki, L.; Ben-Omran, T.; Bindu, P. S.; Blancas, L.; Boisson-Dupuis, S.; Bonnet, D.; Stambouli, O. B.; Bousfiha, A.; Boussafara, L.; Boutros, J.; Bustamante, J.; Caksen, H.; Camcioglu, Y.; Catherinot, E.; Celik, F. C.; Ciancanelli, M.; Cipe, F. E.; Clark, G.; Cobat, A.; Comu, S.; Condie, A.; Condino-Neto, A.; Desai, M.; Dobyns, W.; Dogu, F.; Domaia, M.; Egritas, O.; Azbaoui, S. E.; Baghdadi, J. E.; Ruby, M. E.; El-Harouni, A.; Elfeky,R. A.; Elghazali, G.; Faqeih, E.; Fenerci, E.; Fieschi, C.; Funda, C.; Gamal, I.; Gelik, U.; Genel, F.; Gezdirici, A.; Girisha, K. M.; Goldstein, A.; Grattan-Smith, P.; Gupta, N.; Hahn, J.; Hatipoglu, N.; Hennekam, R.; Houshmand, M.; Ichai, P.; Ikinciogullari, A.; Ismail, S.; Jalas, C.; Jouanguy, E.; Kabra, M.; Kalkan, G.; Kara, M.; Karaca, N.; Karaer, K.; Kariminejad, A.; Kayserili, H.; Keser-Emiroglu, M.; Kilic, S. S.; Kissani, N.; Kokron, C.; Koul, R.; Kutukculer, N.; Lanternier, F.; Mahdaviani, A.; Mahlaoui, N.; Mansour, L.; Mansouri, D.; Margari, L.; Valente, E. M.; Marzouki, N.; Masri, A.; Megahed, A.; Megahed, H.; Mekki, N.; Mesdaghi, M.; Mikati, M.; Mojahedi, F.; Mulley, J.; Nampoothiri, S.; Navarrete, C.; Omar, T.; Oraby, A.; Pandaluz, A.; Parvaneh, N.; Patiroglu, T.; Koc, Z. P.; Pellier, I.; Picard, C.; Puel, A.; Raas-Rothschild, A.; Rajab, A.; Raoult, D.; Reisli, I.; Rezaei, N.; Sabri, A.; Sahin, Y.; Saleem, L.; Salem, F.; AlSediq, N. S.; Sanal, O.; Sanger, T.; Shakankiry, H.; Shang, L.; Shehata, N.; Shembesh, N.; Shkalim, V.; Softah, A.; Sogaty, S.; Soliman, N.; Sonmez Aunaci, F.; Sztriha, L.; Taibi-Berrah, L.; Temtamy, S.; Tonekaboni, H.; Trauner, D.; Tuysuz, B.; Varan, A.; Vogt, G.; Walsh, C.; Woods, G.; Yesil, G.; Yildiran, A.; Yildiz, B.; Yuksel, A.; Zaki, M.; Zhang, S. Y.
Source: Nature Genetics. Unidade: ICB
Subjects: VARIAÇÃO GENÉTICA, GENÉTICA, GENÉTICA DE POPULAÇÕES, IMUNOLOGIA, ALELOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCOTT, Eric M. et al. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nature Genetics, v. 48, n. 9, p. 1071-1076, 2016Tradução . . Disponível em: https://doi.org/10.1038/ng.3592. Acesso em: 16 nov. 2024.
APA
Scott, E. M., Halees, A., Itan, Y., Spencer, E. G., He, Y., Azab, M. A., et al. (2016). Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nature Genetics, 48( 9), 1071-1076. doi:10.1038/ng.3592
NLM
Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG, Consortium GMEV, Alkuraya FS, Casanova JL, Gleeson JG, Rahim SA, Abdel-Hadi S, Abdel-Salam G, Abdel-Salam E, Abdou M, Abhytankar A, Adimi P, Ahmad J, Akcakus M, Aksu G, Hajjar SA, Juamaah SA, Muhsen SA, Sannaa NA, Tameni SA, Al-Aama J, Al-Allawi N, Al-Baradie R, Al-Gazali L, Al-Hashem A, Al-Herz W, Al-Jeaid D, Al-Tawari A, Alangari A, Alcais A, AlFawaz T, Alsum Z, Ammar-Khodja A, Amouian S, Ammar-Khodja A, Arikan C, Aryani O, Aslanger A, Aydogmus C, Aytekin C, Azam M, Bansagi B, Barbouche MR, Bastaki L, Ben-Omran T, Bindu PS, Blancas L, Boisson-Dupuis S, Bonnet D, Stambouli OB, Bousfiha A, Boussafara L, Boutros J, Bustamante J, Caksen H, Camcioglu Y, Catherinot E, Celik FC, Ciancanelli M, Cipe FE, Clark G, Cobat A, Comu S, Condie A, Condino-Neto A, Desai M, Dobyns W, Dogu F, Domaia M, Egritas O, Azbaoui SE, Baghdadi JE, Ruby ME, El-Harouni A, Elfeky RA, Elghazali G, Faqeih E, Fenerci E, Fieschi C, Funda C, Gamal I, Gelik U, Genel F, Gezdirici A, Girisha KM, Goldstein A, Grattan-Smith P, Gupta N, Hahn J, Hatipoglu N, Hennekam R, Houshmand M, Ichai P, Ikinciogullari A, Ismail S, Jalas C, Jouanguy E, Kabra M, Kalkan G, Kara M, Karaca N, Karaer K, Kariminejad A, Kayserili H, Keser-Emiroglu M, Kilic SS, Kissani N, Kokron C, Koul R, Kutukculer N, Lanternier F, Mahdaviani A, Mahlaoui N, Mansour L, Mansouri D, Margari L, Valente EM, Marzouki N, Masri A, Megahed A, Megahed H, Mekki N, Mesdaghi M, Mikati M, Mojahedi F, Mulley J, Nampoothiri S, Navarrete C, Omar T, Oraby A, Pandaluz A, Parvaneh N, Patiroglu T, Koc ZP, Pellier I, Picard C, Puel A, Raas-Rothschild A, Rajab A, Raoult D, Reisli I, Rezaei N, Sabri A, Sahin Y, Saleem L, Salem F, AlSediq NS, Sanal O, Sanger T, Shakankiry H, Shang L, Shehata N, Shembesh N, Shkalim V, Softah A, Sogaty S, Soliman N, Sonmez Aunaci F, Sztriha L, Taibi-Berrah L, Temtamy S, Tonekaboni H, Trauner D, Tuysuz B, Varan A, Vogt G, Walsh C, Woods G, Yesil G, Yildiran A, Yildiz B, Yuksel A, Zaki M, Zhang SY. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery [Internet]. Nature Genetics. 2016 ; 48( 9): 1071-1076.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/ng.3592
Vancouver
Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG, Consortium GMEV, Alkuraya FS, Casanova JL, Gleeson JG, Rahim SA, Abdel-Hadi S, Abdel-Salam G, Abdel-Salam E, Abdou M, Abhytankar A, Adimi P, Ahmad J, Akcakus M, Aksu G, Hajjar SA, Juamaah SA, Muhsen SA, Sannaa NA, Tameni SA, Al-Aama J, Al-Allawi N, Al-Baradie R, Al-Gazali L, Al-Hashem A, Al-Herz W, Al-Jeaid D, Al-Tawari A, Alangari A, Alcais A, AlFawaz T, Alsum Z, Ammar-Khodja A, Amouian S, Ammar-Khodja A, Arikan C, Aryani O, Aslanger A, Aydogmus C, Aytekin C, Azam M, Bansagi B, Barbouche MR, Bastaki L, Ben-Omran T, Bindu PS, Blancas L, Boisson-Dupuis S, Bonnet D, Stambouli OB, Bousfiha A, Boussafara L, Boutros J, Bustamante J, Caksen H, Camcioglu Y, Catherinot E, Celik FC, Ciancanelli M, Cipe FE, Clark G, Cobat A, Comu S, Condie A, Condino-Neto A, Desai M, Dobyns W, Dogu F, Domaia M, Egritas O, Azbaoui SE, Baghdadi JE, Ruby ME, El-Harouni A, Elfeky RA, Elghazali G, Faqeih E, Fenerci E, Fieschi C, Funda C, Gamal I, Gelik U, Genel F, Gezdirici A, Girisha KM, Goldstein A, Grattan-Smith P, Gupta N, Hahn J, Hatipoglu N, Hennekam R, Houshmand M, Ichai P, Ikinciogullari A, Ismail S, Jalas C, Jouanguy E, Kabra M, Kalkan G, Kara M, Karaca N, Karaer K, Kariminejad A, Kayserili H, Keser-Emiroglu M, Kilic SS, Kissani N, Kokron C, Koul R, Kutukculer N, Lanternier F, Mahdaviani A, Mahlaoui N, Mansour L, Mansouri D, Margari L, Valente EM, Marzouki N, Masri A, Megahed A, Megahed H, Mekki N, Mesdaghi M, Mikati M, Mojahedi F, Mulley J, Nampoothiri S, Navarrete C, Omar T, Oraby A, Pandaluz A, Parvaneh N, Patiroglu T, Koc ZP, Pellier I, Picard C, Puel A, Raas-Rothschild A, Rajab A, Raoult D, Reisli I, Rezaei N, Sabri A, Sahin Y, Saleem L, Salem F, AlSediq NS, Sanal O, Sanger T, Shakankiry H, Shang L, Shehata N, Shembesh N, Shkalim V, Softah A, Sogaty S, Soliman N, Sonmez Aunaci F, Sztriha L, Taibi-Berrah L, Temtamy S, Tonekaboni H, Trauner D, Tuysuz B, Varan A, Vogt G, Walsh C, Woods G, Yesil G, Yildiran A, Yildiz B, Yuksel A, Zaki M, Zhang SY. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery [Internet]. Nature Genetics. 2016 ; 48( 9): 1071-1076.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/ng.3592

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration